Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
about
HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition.MiR-142 inhibits the development of cervical cancer by targeting HMGB1The immune contexture in cancer prognosis and treatment.The immune response to secondary necrotic cells.Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy.HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer.Impaired efferocytosis by monocytes in multiple myeloma.Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
P2860
Q37691632-496A925C-0D11-4725-AFDA-2C1954BEE2E9Q37706125-9B184EB5-EF5A-426A-97E7-5DE5D65FB042Q39456999-09651B00-4304-467B-B588-390A2F952B7CQ42371859-1BE5F5FB-6918-44B7-9B1F-8E40282A83CEQ47262101-2710451F-F591-43BD-B95B-89A3D11F2B0CQ55264202-8071AF8C-F836-461E-9B24-12DC8F3E1859Q55310900-809FFE75-8B16-4085-8C15-E4726434CDBDQ56594845-BB9A89AE-945C-4267-A032-2D5D2C9B6926
P2860
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
@en
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
@nl
type
label
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
@en
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
@nl
prefLabel
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
@en
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
@en
P2093
Anna Michlmayr
Guenther Steger
Mercedes Zinn-Zinnenburg
Michael Gnant
Monika Sachet
Peter Dubsky
Rupert Bartsch
Tobias Arnold
P2860
P304
P356
10.1002/CAM4.827
P407
P577
2016-07-25T00:00:00Z